Literature DB >> 16380480

Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability.

Toshiyuki Oshitari1, Peter Polewski, Manish Chadda, An-Fei Li, Tsuyoshi Sato, Sayon Roy.   

Abstract

The effect of combined antisense oligonucleotides (AS-oligos) against overexpression of extracellular matrix (ECM) components, fibronectin, laminin, and collagen IV and on cell monolayer permeability was examined in rat microvascular endothelial cells (RMECs) grown in high glucose medium and on retinal vascular permeability in diabetic rats. RMECs grown in high glucose for 10 days and transfected with combined AS-oligos showed a significantly reduced fibronectin, laminin, and collagen IV protein level. In parallel studies, high-glucose-induced excess monolayer permeability was also reduced in RMECs transfected with the combined AS-oligos. Similarly, diabetic rats intravitreally injected with the combined AS-oligos and examined after 2 months of diabetes showed significant reduction in retinal fibronectin, laminin, and collagen IV expression. In addition, vascular permeability, as determined from extravasation of fluorescein isothiocyanate-BSA in the surrounding areas of the retinal capillaries, was partially reduced in the combined AS-oligos-treated diabetic retinas. Our results indicate that the combined AS-oligos strategy is effective in simultaneously reducing fibronectin, collagen IV, and laminin overexpression and reducing vascular leakage in the retinal capillaries of diabetic rat retinas. The findings suggest that abnormal synthesis of ECM components may contribute to vascular leakage in the diabetic retina.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16380480

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.

Authors:  Sumon Roy; Dongjoon Kim; Cristina Hernández; Rafael Simó; Sayon Roy
Journal:  Exp Eye Res       Date:  2015-08-18       Impact factor: 3.467

Review 2.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.

Authors:  Dongjoon Kim; Robert P Mecham; Ngan-Ha Nguyen; Sayon Roy
Journal:  Exp Eye Res       Date:  2019-05-06       Impact factor: 3.467

Review 4.  Minireview: Fibronectin in retinal disease.

Authors:  Charles G Miller; Greg Budoff; Jonathan L Prenner; Jean E Schwarzbauer
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-20

5.  High glucose-induced downregulation of connexin 30.2 promotes retinal vascular lesions: implications for diabetic retinopathy.

Authors:  Julia Manasson; Thomas Tien; Colleen Moore; Nalin M Kumar; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

6.  FOXO1 plays an essential role in apoptosis of retinal pericytes.

Authors:  Mani Alikhani; Sayon Roy; Dana T Graves
Journal:  Mol Vis       Date:  2010-03-10       Impact factor: 2.367

7.  High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.

Authors:  Argyrios Chronopoulos; Amanda Tang; Ekaterina Beglova; Philip C Trackman; Sayon Roy
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

8.  Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.

Authors:  Yan-Fang Si; Jun Wang; Juan Guan; Li Zhou; Yu Sheng; Juan Zhao
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats.

Authors:  Yugal Behl; Padmaja Krothapalli; Tesfahun Desta; Sayon Roy; Dana T Graves
Journal:  Diabetes       Date:  2009-01-23       Impact factor: 9.461

10.  Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina.

Authors:  Xi-Qin Ding; Alexander B Quiambao; J Browning Fitzgerald; Mark J Cooper; Shannon M Conley; Muna I Naash
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.